Mercer JA - Search Results

1

Predictive models for splenic response to JAK-inhibitor therapy in patients with myelofibrosis.

Menghrajani K, Boonstra PS, Mercer JA, Perkins C, Gowin KL, Weber AA, Mesa R, Gotlib JR, Wang L, Singer JW, Talpaz M. Menghrajani K, et al. Among authors: mercer ja. Leuk Lymphoma. 2019 Apr;60(4):1036-1042. doi: 10.1080/10428194.2018.1509315. Epub 2018 Sep 20. Leuk Lymphoma. 2019. PMID: 30234400 Free PMC article.

2

Induction of p53 suppresses chronic myeloid leukemia.

Peterson LF, Lo MC, Liu Y, Giannola D, Mitrikeska E, Donato NJ, Johnson CN, Wang S, Mercer J, Talpaz M. Peterson LF, et al. Leuk Lymphoma. 2017 Sep;58(9):1-14. doi: 10.1080/10428194.2016.1272682. Epub 2017 Jan 13. Leuk Lymphoma. 2017. PMID: 28084835

3

A provider's guide to primary myelofibrosis: pathophysiology, diagnosis, and management.

Garmezy B, Schaefer JK, Mercer J, Talpaz M. Garmezy B, et al. Blood Rev. 2021 Jan;45:100691. doi: 10.1016/j.blre.2020.100691. Epub 2020 Apr 7. Blood Rev. 2021. PMID: 32354563 Review.

4

Late Responses in Patients With Chronic Myeloid Leukemia Initially Refractory to Tyrosine Kinase Inhibitors.

Shaya J, Pettit K, Kandarpa M, Bixby D, Mercer J, Talpaz M. Shaya J, et al. Clin Lymphoma Myeloma Leuk. 2022 Jan;22(1):17-23. doi: 10.1016/j.clml.2021.07.001. Epub 2021 Jul 18. Clin Lymphoma Myeloma Leuk. 2022. PMID: 34462243 Free article. Review.

5

Re-emergence of interferon-α in the treatment of chronic myeloid leukemia.

Talpaz M, Hehlmann R, Quintás-Cardama A, Mercer J, Cortes J. Talpaz M, et al. Leukemia. 2013 Apr;27(4):803-12. doi: 10.1038/leu.2012.313. Epub 2012 Nov 7. Leukemia. 2013. PMID: 23238589 Free PMC article. Review.

6

The interferon-alpha revival in CML.

Talpaz M, Mercer J, Hehlmann R. Talpaz M, et al. Ann Hematol. 2015 Apr;94 Suppl 2:S195-207. doi: 10.1007/s00277-015-2326-y. Epub 2015 Mar 27. Ann Hematol. 2015. PMID: 25814086 Review.

7

Evaluating Acalabrutinib In The Treatment Of Mantle Cell Lymphoma: Design, Development, And Place In Therapy.

Girard J, Reneau J, Devata S, Wilcox RA, Kaminski MS, Mercer J, Carty S, Phillips TJ. Girard J, et al. Onco Targets Ther. 2019 Sep 30;12:8003-8014. doi: 10.2147/OTT.S155778. eCollection 2019. Onco Targets Ther. 2019. PMID: 31686856 Free PMC article.

8

Surveillance Scans in Lymphoma: Friend or Foe?

Phillips T, Mercer J. Phillips T, et al. Curr Treat Options Oncol. 2017 Feb;18(2):10. doi: 10.1007/s11864-017-0451-7. Curr Treat Options Oncol. 2017. PMID: 28214975 Review.

9

Continuous evolution of compact protein degradation tags regulated by selective molecular glues.

Mercer JAM, DeCarlo SJ, Roy Burman SS, Sreekanth V, Nelson AT, Hunkeler M, Chen PJ, Donovan KA, Kokkonda P, Tiwari PK, Shoba VM, Deb A, Choudhary A, Fischer ES, Liu DR. Mercer JAM, et al. Science. 2024 Mar 15;383(6688):eadk4422. doi: 10.1126/science.adk4422. Epub 2024 Mar 15. Science. 2024. PMID: 38484051

10

Proteolysis-targeting chimeras with reduced off-targets.

Nguyen TM, Sreekanth V, Deb A, Kokkonda P, Tiwari PK, Donovan KA, Shoba V, Chaudhary SK, Mercer JAM, Lai S, Sadagopan A, Jan M, Fischer ES, Liu DR, Ebert BL, Choudhary A. Nguyen TM, et al. Among authors: mercer jam. Nat Chem. 2024 Feb;16(2):218-228. doi: 10.1038/s41557-023-01379-8. Epub 2023 Dec 18. Nat Chem. 2024. PMID: 38110475 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

140 results

Search Page